Foster Dykema Cabot & Partners, LLC Royalty Pharma PLC Call Options Transaction History
Foster Dykema Cabot & Partners, LLC
- $1.42 Trillion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RPRX
# of Institutions
509Shares Held
309MCall Options Held
1.99MPut Options Held
384K-
Morgan Stanley New York, NY46.6MShares$1.72 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.4MShares$1.34 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$850 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA21.9MShares$808 Million0.14% of portfolio
-
Baillie Gifford & CO17.4MShares$642 Million0.48% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $16.1B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...